We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-3.82%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.14B
AUM Growth
-$348M
Cap. Flow
-$183M
Cap. Flow %
-8.54%
Top 10 Hldgs %
19.87%
Holding
278
New
28
Increased
51
Reduced
132
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 21.41%
2 Industrials 17.43%
3 Consumer Discretionary 17.37%
4 Technology 13.96%
5 Financials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOO icon
26
Steven Madden
SHOO
$3.17B
$28.4M 1.33%
793,613
-62,272
-7% -$2.06M
HAE icon
27
Haemonetics
HAE
$3.54B
$25.7M 1.2%
203,640
+22,470
+12% +$2.85M
OLLI icon
28
Ollie's Bargain Outlet
OLLI
$4.02B
$24.7M 1.16%
421,918
+112,493
+36% +$8.44M
TDOC icon
29
Teladoc Health
TDOC
$1.7B
$24.3M 1.13%
358,400
-240,233
-40% -$15.8M
PPBI
30
DELISTED
Pacific Premier Bancorp
PPBI
$23.5M 1.1%
754,953
-54,187
-7% -$1.65M
RDUS
31
DELISTED
Radius Health, Inc.
RDUS
$23.2M 1.09%
902,467
+240,354
+36% +$5.89M
RETA
32
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$22.7M 1.06%
282,818
-104,551
-27% -$8.87M
PS
33
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$22.5M 1.05%
1,341,757
+456,548
+52% +$9.83M
GTLS icon
34
Chart Industries
GTLS
$21.4M 1%
343,393
-23,448
-6% -$1.59M
TRHC
35
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$21.2M 0.99%
385,900
+79,797
+26% +$4.57M
PLCE icon
36
Children's Place
PLCE
$65.8M
$21.1M 0.99%
274,197
-17,371
-6% -$1.53M
NSP icon
37
Insperity
NSP
$1.89B
$20.6M 0.96%
209,156
-14,955
-7% -$1.62M
AEO icon
38
American Eagle Outfitters
AEO
$2.85B
$20.5M 0.96%
1,263,554
-96,444
-7% -$1.61M
ATSG
39
DELISTED
Air Transport Services Group
ATSG
$19.2M 0.9%
913,481
-76,233
-8% -$1.66M
YETI icon
40
Yeti Holdings
YETI
$3.87B
$17.7M 0.83%
631,668
+46,823
+8% +$1.42M
MNTV
41
DELISTED
Momentive Global Inc. Common Stock
MNTV
$17.7M 0.82%
1,032,408
+24,570
+2% +$428K
CCOI icon
42
Cogent Communications
CCOI
$549M
$17.5M 0.82%
317,863
-27,319
-8% -$1.63M
INSM icon
43
Insmed
INSM
$23.5B
$17.4M 0.81%
984,987
+69,468
+8% +$1.34M
PFPT
44
DELISTED
Proofpoint, Inc.
PFPT
$17.2M 0.8%
132,978
-40,808
-23% -$4.99M
MODN
45
DELISTED
MODEL N, INC.
MODN
$17.1M 0.8%
616,591
-47,306
-7% -$1.17M
OCFC icon
46
OceanFirst Financial
OCFC
$1.73B
$16.8M 0.78%
710,661
-35,450
-5% -$825K
ADUS icon
47
Addus HomeCare
ADUS
$2.14B
$16.8M 0.78%
211,295
-16,803
-7% -$1.36M
NVEE
48
DELISTED
NV5 Global
NVEE
$16.6M 0.77%
970,356
-168,916
-15% -$3.07M
AJRD
49
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$16.5M 0.77%
+327,583
New +$15.9M
VCRA
50
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$16.3M 0.76%
660,940
-62,806
-9% -$1.63M

Similar funds

Emerald Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Emerald Advisers held 278 positions worth $2.14B, down 14% from $2.49B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers withdrew a net $183M in Q3 2019, closing 33 positions and reducing 132 holdings. Its most notable exit was Cray, Inc., an estimated $24.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Aerojet Rocketdyne Holdings worth $16.5M.

  • Emerald Advisers's largest Q3 2019 buy was Aerojet Rocketdyne Holdings: 327,583 shares worth $16.5M.
  • Emerald Advisers added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $9.83M increase.
  • Emerald Advisers's biggest Q3 2019 reduction was Teladoc Health, cutting an estimated $15.8M.
  • Emerald Advisers fully exited Cray, Inc. in Q3 2019, selling an estimated $24.4M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.14B portfolio in Q3 2019.
  • Emerald Advisers opened 28 new positions and closed 33 in Q3 2019.
  • Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.14B.

Based on Emerald Advisers's 13F filing for Q3 2019, filed 31 Oct 2019.